Scarneo, Scott A <br/><br/>
Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice.  [electronic resource] 

 -  Arthritis research & therapy  12 2019 
 - 292 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-019-2073-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arthritis, Experimental--metabolism<br/>Arthritis, Rheumatoid--metabolism<br/>Benzamides--pharmacokinetics<br/>Benzimidazoles--pharmacokinetics<br/>Cells, Cultured<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Fibroblasts--drug effects<br/>Humans<br/>Inflammation--metabolism<br/>Knee Joint--drug effects<br/>MAP Kinase Kinase Kinases--antagonists & inhibitors<br/>Mice, Inbred DBA<br/>Protein Kinase Inhibitors--pharmacology<br/>Severity of Illness Index<br/>Synoviocytes--drug effects